Table 5.
PPL Characteristics in Pediatric vs Adult Patients
| Characteristics | Patients <18 Year n (%) |
Patients >18 Years n (%) |
|---|---|---|
| Presenting symptoms | ||
| Abdominal pain | 16/21 (76.2) | 159/211 (75.4) |
| Jaundice | 13 (61.9) | 87/218 (39.9) |
| B symptoms | 2 (9.52) | 75/220 (34.1) |
| GI obstruction | 1 (4.76) | 23/204 (11.3) |
| Acute pancreatitis | 10 (47.6) | 55/197 (27.9) |
| Laboratory values | ||
| LDH > upper limits | 8/10 (80) | 57/119 (47.9) |
| CA 19–9 > upper limits | 0/3 (0) | 32/116 (27.6) |
| Pancreatic localization | ||
| Head | 13/21 (61.9) | 150/235 (63.8) |
| Body-tail | 2 (9.5) | 74 (31.5) |
| All gland | 6 (28.6) | 11 (4.7) |
| Histology | ||
| DLBCL | 5/21 (23.8) | 138/245 (56.3) |
| BL | 11 (52.4) | 9 (3.7) |
| High grade B cell lymphoma | 1 (4.8) | 13 (5.3) |
| T-NHL | 2 (9.5) | 17 (6.9) |
| Unknown | 2 (9.5) | 29 (11.8) |
| Clinical stage (Ann Arbor) | ||
| I–II | 5/13 (38.5) | 147/187 (78.6) |
| III–IV | 8 (61.5) | 40/187 (21.4) |
Abbreviations: GI, gastrointestinal; LDH, lactate dehydrogenase; CA 19–9, carbohydrate antigen; WBC, white blood cells; DLBCL, diffuse large B cell lymphoma; BL, Burkitt lymphoma; NHL, non Hodgkin lymphoma.